Skip to Content

Virtus NFJ Small-Cap Value A PCVAX

Analyst rating as of
NAV / 1-Day Return
14.30  /  1.24 %
Total Assets
484.9 Mil
Adj. Expense Ratio
1.170%
Expense Ratio
1.170%
Fee Level
Below Average
Longest Manager Tenure
26.06 years
Category
Small Value
Investment Style
Small Value
Min. Initial Investment
2,500
Status
Open
TTM Yield
1.05%
Turnover
65%
Premium

Morningstar’s Analysis

Will PCVAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Ceasing Coverage of Virtus NFJ Small-Cap Value

Senior Analyst

Analyst Note

| |

Morningstar will cease qualitative research coverage of Virtus NFJ Small-Cap Value on or about March 13, 2022, in order to reallocate our analysts to research other strategies. At that time, the last Morningstar Analyst Rating and this research will be removed. After that date, please discontinue using the research report or former research reports issued by Morningstar on this fund. We recommend users form their own views on this fund or obtain financial advice.

Unlock our full analysis with Morningstar Premium